PolyPid Ltd. (PYPD)
NASDAQ·Healthcare·Biotechnology
$5.13
-0.58%
Mkt Cap $42.60M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$12.50
Range $12.00 – $13.00
Implied Upside
+143.7%
Consensus $12.50 vs current $5.13
NASDAQ·Healthcare·Biotechnology
$5.13
-0.58%
Mkt Cap $42.60M
No recent rating data.
Price Target (4 analysts)
$12.50
Range $12.00 – $13.00
+143.7%
Consensus $12.50 vs current $5.13